This proposed algorithm provides guidance for the management of children with abnormal TCD velocities, including decision points regarding the initiation or discontinuation of chronic blood transfusions and hydroxyurea therapy. HbS, sickle hemoglobin; MRA, magnetic resonance angiography; MRI, magnetic resonance imaging.